ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE - Generic Drug Details

What are the generic drug sources for acetaminophen; tramadol hydrochloride and what is the scope of freedom to operate?

Acetaminophen; tramadol hydrochloride is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Amneal Pharms, Aurobindo Pharma, Chartwell Rx, Graviti Pharms, Macleods Pharms Ltd, Micro Labs Ltd India, Mpp Pharma, Rising, Sun Pharm Inds Inc, Zydus Pharms Usa Inc, and Janssen Pharms, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

Thirteen suppliers are listed for this compound.

Summary for ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE

US Patents:	0
Tradenames:	2
Applicants:	12
NDAs:	12
Finished Product Suppliers / Packagers:	13
Clinical Trials:	90
DailyMed Link:	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE at DailyMed

Recent Clinical Trials for ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation	PHASE4
Texas Scottish Rite Hospital for Children	PHASE2
The Methodist Hospital Research Institute	PHASE1

See all ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE clinical trials

Pharmacology for ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE

Drug Class	Opioid Agonist
Mechanism of Action	Full Opioid Agonists

Anatomical Therapeutic Chemical (ATC) Classes for ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE

N02AX	Other opioids
N02A	OPIOIDS
N02	ANALGESICS
N	Nervous system

US Patents and Regulatory Information for ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mpp Pharma	TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN	acetaminophen; tramadol hydrochloride	TABLET;ORAL	078778-001	Apr 7, 2014		DISCN	No	No
Alkem Labs Ltd	TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN	acetaminophen; tramadol hydrochloride	TABLET;ORAL	202076-001	Mar 30, 2012	AB	RX	No	No
Rising	TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN	acetaminophen; tramadol hydrochloride	TABLET;ORAL	077858-001	Sep 26, 2008	AB	RX	No	No
Sun Pharm Inds Inc	TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN	acetaminophen; tramadol hydrochloride	TABLET;ORAL	077184-001	Dec 16, 2005		DISCN	No	No
Chartwell Rx	TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN	acetaminophen; tramadol hydrochloride	TABLET;ORAL	076475-001	Apr 21, 2005		DISCN	No	No
Janssen Pharms	ULTRACET	acetaminophen; tramadol hydrochloride	TABLET;ORAL	021123-001	Aug 15, 2001		DISCN	Yes	No
Macleods Pharms Ltd	TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN	acetaminophen; tramadol hydrochloride	TABLET;ORAL	206885-001	May 2, 2017		DISCN	No	No

Expired US Patents for ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Janssen Pharms	ULTRACET	acetaminophen; tramadol hydrochloride	TABLET;ORAL	021123-001	Aug 15, 2001	5,336,691
Janssen Pharms	ULTRACET	acetaminophen; tramadol hydrochloride	TABLET;ORAL	021123-001	Aug 15, 2001	RE39221

Market Dynamics and Financial Trajectory for Acetaminophen and Tramadol Hydrochloride

Last updated: February 14, 2026

What Is the Current Market Size and Revenue for Acetaminophen and Tramadol Hydrochloride?

Acetaminophen (paracetamol) and tramadol hydrochloride serve integral roles in pain and fever management. Their market sizes reflect their widespread use, regulatory factors, and emerging competition.

• Global acetaminophen market (2022): Estimated at USD 4.2 billion, projected to reach USD 6.0 billion by 2030, growing at a CAGR of 4.5%. Factors include high consumption in OTC formulations and emerging markets.[1]

• Global tramadol market (2022): Valued at USD 1.8 billion, anticipated to grow to USD 2.9 billion by 2030 at a CAGR of 5.8%. Rise driven by increasing chronic pain prevalence and expanding approval in developing regions.[2]

How Do Regulatory Factors Impact Market Distribution and Revenue?

Acetaminophen:
Regulations restrict high-dose formulations in some countries due to hepatotoxicity risks. U.S. FDA limits dosage and mandates clear labeling. These regulations influence manufacturing, sales, and product innovation.

Tramadol hydrochloride:
Classified as a controlled substance in multiple jurisdictions due to abuse potential. Use restrictions and scheduling (e.g., Schedule IV in the U.S.) reduce market access, impact prescription volumes, and drive illicit channel concerns. Regulatory scrutiny influences patent status, generic entry, and pricing strategies.

What Are Key Trends Affecting Market Competition?

Generic Penetration and Patent Lifecycle

• Acetaminophen:
  Patent expirations occurred decades ago, facilitating an extensive generic market. Over 1,000 manufacturers globally produce acetaminophen, intensifying price competition and reducing profit margins.

• Tramadol hydrochloride:
  Patent expiration occurred around 2010 in multiple markets, leading to high generic availability. The landscape has seen multiple entrants, pressuring branded prices.

Innovation and New Formulations

• Acetaminophen:
  Limited recent innovation; focus remains on formulations with extended release, combination products, and novel delivery systems.

• Tramadol hydrochloride:
  Recent developments include abuse-deterrent formulations aimed at reducing misuse and formulations combining tramadol with other agents for expanded analgesic effects.

Distribution Channels

• Over-the-counter distribution dominates acetaminophen markets, especially in lower-income countries, further driven by retail pharmacies and online outlets.

• Tramadol, primarily prescription-based, faces stricter dispensing controls, which influence distribution margins and access.

How Do Pricing and Reimbursement Policies Influence Financial Outcomes?

Acetaminophen:
Being OTC, prices are influenced by manufacturing costs, retailer markups, and competitive pressures. Reimbursement is generally not applicable, limiting revenue to direct sales.

Tramadol hydrochloride:
Reimbursement schemes affect sales via insurance coverage, especially for branded formulations. Controlled substance regulations impact prescribing frequency and dosage limits, affecting overall revenues.

What Are Future Market Drivers and Challenges?

Drivers

• Rising chronic pain and osteoarthritis prevalence increase demand.

• Increasing geriatric population enhances consumption patterns.

• Preference shifts towards combination therapies and novel delivery mechanisms.

Challenges

• Regulatory restrictions on abuse-prone opioids like tramadol.

• Public health campaigns reducing opioid use curb market growth.

• Market saturation due to generic competition reduces margins.

How Do Competitive Strategies Differ?

• Acetaminophen:
  Focus on cost leadership, brand consolidation in emerging markets, and developing extended-release formulations.

• Tramadol hydrochloride:
  Investments in abuse-deterrent formulations, expanding indications, and strategic alliances with insurance providers aim to stabilize revenues amid regulatory challenges.

What Are the Key Financial Metrics to Track?

• Sales volume trends: Reflect demand shifts and market penetration.

• Pricing strategies: Affected by patent status, generic competition, and regulation.

• Profit margins: Dependent on manufacturing costs, R&D investments, and market positioning.

• Market share changes: Driven by product innovation and regulatory compliance.

References

[1] Grand View Research. (2022). Acetaminophen Market Size & Trends.
[2] Fortune Business Insights. (2022). Tramadol Hydrochloride Market Analysis.

---

Key Takeaways

• The acetaminophen market is highly saturated with generic manufacturers; growth hinges on formulation innovations and market expansion, especially in emerging economies.
• Tramadol faces regulatory challenges worldwide, impacting market size, but new formulations and abuse-deterrent strategies help offset revenue pressures.
• Regulatory environments significantly influence pricing, distribution, and profitability for both drugs.
• The aging population and chronic pain increase demand, but regulatory scrutiny remains a persistent challenge.
• Competitive dynamics favor companies investing in formulation innovation, compliance, and strategic partnerships.

---

FAQs

1. How do patent expirations affect the market for these drugs?
Patent expirations lead to increased generic competition, reducing prices and profit margins. This drives companies to innovate or diversify formulations for market differentiation.

2. Are there pipeline developments for acetaminophen or tramadol?
Limited pipeline activity exists; most innovation focuses on new formulations, combination therapies, or abuse-deterrent features rather than entirely new chemical entities.

3. What regulatory changes could impact future revenues?
Stricter controls on tramadol due to abuse concerns and dosage regulations for acetaminophen could limit prescribing and sales, influencing overall revenue trajectories.

4. How significant is the OTC market for acetaminophen?
OTC sales constitute the majority of acetaminophen revenue, especially in developed countries. OTC access expands market reach but limits pricing power.

5. What opportunities exist in emerging markets?
High unmet medical needs and growing healthcare infrastructure create opportunities for market penetration through affordable formulations and distribution channels.

---

Citations

[1] Grand View Research. (2022). Acetaminophen Market Size & Trends.

[2] Fortune Business Insights. (2022). Tramadol Hydrochloride Market Analysis.